| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/22/2009 | WO2009011854A1 Identifying brain loci and protein specificity of cells that determine mental states |
| 01/22/2009 | WO2009011770A2 Compositions and methods for diagnosing and assesing inflammatory myopathies |
| 01/22/2009 | WO2009011602A1 Ovine identification method |
| 01/22/2009 | WO2009011472A1 Primers and proves for detection of high risk group geno-type human papillomavirus dna, a qualitative assay method of the same dna using them and a qualitative assay kit of the same dna |
| 01/22/2009 | WO2009011426A1 Screening method utilizing c-met which is novel substrate for γ-secretase |
| 01/22/2009 | WO2009011297A1 Probe for detecting mutation in jak2 gene and use thereof |
| 01/22/2009 | WO2009011277A1 Oligonucleotide for detection and identification of acid-fast bacterium, and use thereof |
| 01/22/2009 | WO2009010976A2 Compositions and methods for purifying and crystallizing molecules of interest |
| 01/22/2009 | WO2009010776A1 Detection of methylation in nucleic acid sequence |
| 01/22/2009 | WO2009010687A2 Target enzyme in the treatment of acne |
| 01/22/2009 | WO2009010279A1 Positive controls for expression modulating experiments |
| 01/22/2009 | WO2009010121A1 Phosphorylation of histone h3 at threonine 11 - a novel epigenetic mark for transcriptional regulation |
| 01/22/2009 | WO2009009908A1 A recombmase based screening method for detecting molecular interactions comprising a single plasmid vector with two unique recombmase sites |
| 01/22/2009 | WO2009009900A1 Nucleic acid sequences for the amplification and detection of respiratory viruses |
| 01/22/2009 | WO2009009890A1 Ovarian cancer biomarkers |
| 01/22/2009 | WO2009009889A1 Ultrasensitive detection of target using target-ready particles |
| 01/22/2009 | WO2009009836A1 Genetic basis for improved milling performance |
| 01/22/2009 | WO2008151110A3 Molecular diagnosis and typing of lung cancer variants |
| 01/22/2009 | WO2008146309A3 Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment |
| 01/22/2009 | WO2008145795A3 Method and kit for genotyping of dicentrarchus lahrax |
| 01/22/2009 | WO2008136988A3 Polymorphisms in genes affecting cyp2c9-related disorders and uses thereof |
| 01/22/2009 | WO2008134524A3 Compositions and methods for regulating t-cell activity |
| 01/22/2009 | WO2008133728A3 Sequential analysis of biological samples with intermediate bleaching of fluorescence detector |
| 01/22/2009 | WO2008130394A3 Array for detecting microbes |
| 01/22/2009 | WO2008121830A3 Phage receptor binding proteins for antibacterial therapy and other novel uses |
| 01/22/2009 | WO2008119332A3 Method for the detection of paratuberculosis |
| 01/22/2009 | WO2008116161A3 Pyrazoloanthrone and derivatives thereof for the treatment of cancer expressing 'mullerian inhibiting substance' type ii receptor (misrii) and of excess androgen states |
| 01/22/2009 | WO2008086342A3 Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in prostate cells |
| 01/22/2009 | WO2008082673A3 Companion diagnostic assays for cancer therapy |
| 01/22/2009 | WO2008082519A3 Screening for cd93 (c1qrp)-associated polymorphism(s) in the diagnosis, prevention and treatment of autoimmune diseases |
| 01/22/2009 | WO2008014400A8 Crohn disease susceptibility gene |
| 01/22/2009 | WO2006055322A3 High arachidonic acid producing strains of yarrowia lipolytica |
| 01/22/2009 | WO2001092300A9 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 01/22/2009 | US20090025101 Plant Yield Improvement By Ste20-Like Gene Expression |
| 01/22/2009 | US20090025096 P4has as modifiers of the igfr pathway and methods of use |
| 01/22/2009 | US20090024401 Involvement of a Novel Nuclear-Encoded Mitochondrial Poly(A) Polymerase PAPD1 in Extreme Obesity-Related Phenotypes in Mammals |
| 01/22/2009 | US20090023928 Phthalamide-lanthanide complexes for use as luminescent markers |
| 01/22/2009 | US20090023910 Applications with and Methods for Producing Selected Interstrand Cross-Links in Nucleic Acids |
| 01/22/2009 | US20090023909 Blueberry red ringspot virus, sequences, promoters, and uses thereof |
| 01/22/2009 | US20090023810 Methods of translation and/or inflammation blockade |
| 01/22/2009 | US20090023794 Use of Sumoylation Inhibitors for the Treatment of Neurodegenerative Disease |
| 01/22/2009 | US20090023674 snRNA gene-like transcriptional units and uses thereof |
| 01/22/2009 | US20090023659 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 01/22/2009 | US20090023657 Catecholamine regulated protein |
| 01/22/2009 | US20090023655 Biased Ligands for Receptors Such as the PTH Receptor |
| 01/22/2009 | US20090023651 Inhibitors of human plasmin derived from the kunitz domains |
| 01/22/2009 | US20090023649 for treating diseases relating to angiogenesis; fusion protein possesses ribosome inactivating activity and ability to bind to cellular vascular endothelial growth factor (VEGF) receptors |
| 01/22/2009 | US20090023645 AIB1, a novel steroid receptor co-activator |
| 01/22/2009 | US20090023630 Methods and Means for Use in Diagnostics and Treatment of Diabetes |
| 01/22/2009 | US20090023610 Removable microfluidic cell |
| 01/22/2009 | US20090023600 Device and Process for Measuring Cell Properties |
| 01/22/2009 | US20090023598 Method for extracting quantitative information relating to an influence on a cellular response |
| 01/22/2009 | US20090023597 Single Nucleotide Polymorphism Detection from Unamplified Genomic DNA |
| 01/22/2009 | US20090023594 Reagents for labelling nucleic acids and uses thereof |
| 01/22/2009 | US20090023593 In situ cloning from pathological tissue specimens |
| 01/22/2009 | US20090023592 System for identifying and analyzing expression of are-containing genes |
| 01/22/2009 | US20090023591 Cardiac hormones for assessing cardiovascular risk |
| 01/22/2009 | US20090023207 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |
| 01/22/2009 | US20090023181 Method and Device for Detection of Erythromycin-Induced Clindamycin Resistance |
| 01/22/2009 | US20090023180 Reduction of Shading in Microalgae |
| 01/22/2009 | US20090023179 Reagent, Medium, and Method for Detection of Alicyclobacilus Acidoterrestris |
| 01/22/2009 | US20090023178 Parkin Substrate and Assay |
| 01/22/2009 | US20090023177 Assays and methods for determining stim2 activity |
| 01/22/2009 | US20090023176 Devices, systems and methods for isometric and isotonic contraction of blood vessels using an isovolumetric myograph |
| 01/22/2009 | US20090023175 Device for sampling a fluid and detecting an analyte therein |
| 01/22/2009 | US20090023174 Methods and compositions for detecting immune responses |
| 01/22/2009 | US20090023173 Luminescence-based methods and probes for measuring cytochrome P450 activity |
| 01/22/2009 | US20090023172 identifying antifungal agents based on fungal GTP cyclohydrolase II; adding GTP, NAD+ and formate dehydrogenase to a sample comprising GTP cyclohydrolase II or I, determining production of NADH, and correlating the production of NADH with GTP I or II activity |
| 01/22/2009 | US20090023171 Method for determining specific groups constituting heparins or low molecular weight heparins |
| 01/22/2009 | US20090023170 Methods And Kits For The Detection of Biotoxic and Antibiotic Residues |
| 01/22/2009 | US20090023169 High throughput sarcomeric assay |
| 01/22/2009 | US20090023168 Method of screening placental proteins responsible for pathophysiology of preeclampsia, and marker for early diagnosis and prediction of preeclampsia |
| 01/22/2009 | US20090023167 Method, reagent and kit for determination of cholesterol in remnant-like particles (rlp) |
| 01/22/2009 | US20090023166 Method For the in Vitro Diagnosis of Autoimmune Immune Response by Detection of Antibodies Directed Against The Pentraxin 3 Antigen |
| 01/22/2009 | US20090023163 Method of Measuring Enzyme Activity and Method of Evaluating Compound |
| 01/22/2009 | US20090023158 Compositions and Methods for Identifying Substrate Specificity of Inhibitors of Gamma Secretase |
| 01/22/2009 | US20090023157 Proteome epitope tags and methods of use thereof in protein modification analysis |
| 01/22/2009 | US20090023154 Relating to marking |
| 01/22/2009 | US20090023153 Targeted modification of chromatin structure |
| 01/22/2009 | US20090023152 Transcription factor MHC class II genes, substances capable of inhibiting this transcription factor and medical uses of these substances |
| 01/22/2009 | US20090023151 Method For The Labeling And Detection Of Small Polynucleotides |
| 01/22/2009 | US20090023150 Amplifying target nucleic acid molecules; ionizing and volatilizing; analyzing the product using mass spectrometry to determine an observed molecular mass; diagnosing a genetic disease, chromosomal abnormality |
| 01/22/2009 | US20090023149 Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy |
| 01/22/2009 | US20090023148 rapid, sensitive, and accurate method that can be used to measure nearly any analyte; employed to visualize the relationship between gene expression and tissue morphology |
| 01/22/2009 | US20090023147 Diagnostics and therapeutics for osteoporosis |
| 01/22/2009 | US20090023146 Device for processing an analyte and a method of processing and/or detecting an analyte using said device |
| 01/22/2009 | US20090023145 Methods of diagnosing or prognosing Alzheimer's disease |
| 01/22/2009 | US20090023144 Method and its kit for quantitatively detecting specific analyte with single capturing agent |
| 01/22/2009 | US20090023143 Predicting agent for metastasis |
| 01/22/2009 | US20090023142 Methods for Detecting Minimum Residual Disease |
| 01/22/2009 | US20090023141 Method for detecting bacteria of the genus mycobacterium (acid-fast bacteria) and kit for the same |
| 01/22/2009 | US20090023140 Crosslinking agent, crosslinking method, method of controlling gene expression, and method of examining gene function |
| 01/22/2009 | US20090023139 Method For Site-Specifically Introducing Non-Natural Amino Acid Into Protien Using Mitochondrial Protein and Method For Effectively Preparing Trna |
| 01/22/2009 | US20090023138 Oral cancer markers and their detection |
| 01/22/2009 | US20090023137 ESR1 and Cervical Cancer |
| 01/22/2009 | US20090023136 HSD3B1 sequence variants |
| 01/22/2009 | US20090023135 Detection of enhanced multiplex signals by surface enhanced raman spectroscopy |
| 01/22/2009 | US20090023134 Neoplasia diagnostic compositions and methods of use |
| 01/22/2009 | US20090023133 determining nucleotide positioning in genome for diagnosis, prognosis |
| 01/22/2009 | US20090022825 Method for Predicting Whether Subjects With Mild Cognitive Impairment (MCI) Will Develop Alzheimer's Disease |